Doctor Olgierd Wozniak

National Institute of Cardiology, Warsaw (Poland)

Follow

Contributor content

NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy

Presentation

NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy

ESC 365 is supported by

novartis

Explore sponsored resources